India to Zimbabwe: Ustekinumab Export Trade Route

The India to Zimbabwe Ustekinumab corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $737 USD. The route is dominated by RUTVA MEDICARE, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ustekinumab manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $246 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 28.8%, placing it at rank #1 among India's top ustekinumab export destinations globally.

On the import side, key buyers of Indian ustekinumab in Zimbabwe include TO THE ORDER OF-, TO THE ORDER OF. TO THE ORDER OF- is the single largest importer with 2 shipments valued at $609 USD.

India's ustekinumab exports to Zimbabwe are driven primarily by a handful of large-scale manufacturers. RUTVA MEDICARE with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Zimbabwe benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — RUTVA MEDICARE — together account for 100% of total trade value on this route. The average shipment value of $246 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine for human consumptionas per given invoice ustekinumab 45mg, suggesting that buyers in Zimbabwe tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF- is the largest importer with 2 shipments worth $609 USD — representing 83% of all ustekinumab imports from India on this route.